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Abstract: Background: Acceleration of mass vaccination strategies is the only pathway to overcome 
the COVID-19 pandemic. Healthcare professionals and students have a key role in shaping public 
opinion about vaccines. This study aimed to evaluate the attitudes of dental students globally to-
wards COVID-19 vaccines and explore the potential drivers for students’ acceptance levels. Meth-
ods: A global cross-sectional study was carried out in February 2021 using an online questionnaire. 
The study was liaised by the scientific committee of the International Association of Dental Students 
(IADS), and data were collected through the national and local coordinators of IADS member or-
ganizations. The dependent variable was the willingness to take the COVID-19 vaccine, and the 
independent variables included demographic characteristics, COVID-19-related experience, and 
the drivers of COVID-19 vaccine-related attitude suggested by the WHO SAGE. Results: A total of 
6639 students from 22 countries, representing all world regions, responded to the questionnaire 
properly. Their mean age was 22.1 ± 2.8 (17–40) years, and the majority were females (70.5%), in 
clinical years (66.8%), and from upper-middle-income economies (45.7%). In general, 22.5% of den-
tal students worldwide were hesitant, and 13.9% rejected COVID-19 vaccines. The students in low- 
and lower-middle-income (LLMI) economies had significantly higher levels of vaccine hesitancy 
compared to their peers in upper-middle- and high-income (UMHI) economies (30.4% vs. 19.8%; p 
< 0.01). Conclusions: The global acceptance level of dental students for COVID-19 vaccines was 
suboptimal, and their worrisome level of vaccine hesitancy was influenced by the socioeconomic 
context where the dental students live and study. The media and social media, public figures, in-
sufficient knowledge about vaccines, and mistrust of governments and the pharmaceutical industry 
were barriers to vaccination. The findings of this study call for further implementation of epidemi-
ology (infectious diseases) education within undergraduate dental curricula. 
Keywords: COVID-19 vaccines; cross-sectional studies; decision making; dental education; dental 
students; international association of dental students; mass vaccination; multicentre study; social 
determinants of health 
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Vaccine hesitancy (VH) is defined by the World Health Organization (WHO) Strate-
gic Advisory Group of Experts on Immunization (SAGE) as a “delay in acceptance or re-
fusal of vaccination despite the availability of vaccination services” [1]. Given the urgency 
of mass vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) strategies, VH is increasingly recognized as a serious public health threat that requires 
thorough investigation among various population groups to fully understand its drivers 
as well as its prevalence [2,3]. 
However, healthcare workers (HCWs) are usually perceived by their patients as the 
most reliable information source about vaccines; this group sometimes shows different 
levels of VH [4,5]. Karafillakis et al. (2016) found that the fear of vaccine side effects, ap-
prehension of new vaccines due to lack of safety data, and mistrust of pharmaceutical 
companies due to financial interests were the most prominent drivers of VH among 
HCWs in Europe [6]. Unfortunately, all these issues are relevant to the context of corona-
virus disease 2019 (COVID-19) vaccines recently produced through intensified manufac-
turing processes and used through emergency use authorization (EUA) [7]. 
Dental students represent a particular subset of the healthcare students’ population 
who will play a key role in shaping their patients’ health-related attitudes and behaviours 
in the near future, as they are perceived as role models of a healthy lifestyle [8]. Adopting 
positive health-related beliefs and attitudes by HCWs increases their preparedness and 
capacity to counsel patients on behavioural changes [9]. Therefore, self-care is a core com-
petency of medical education and a cost-effective public health policy for sustainable 
health promotion [10,11]. Moreover, medical students retain the highest levels of health-
related knowledge and attitudes, making them the opinion leaders of public health issues 
among the university students’ community [12]. 
Additionally, dental students differ from the general university student population 
because they are prone to an increased risk of contracting infectious diseases as part of 
their clinical training requirement [13]. Therefore, they are obliged to receive certain vac-
cines prior to joining the clinical years of their undergraduate courses, including hepatitis 
B, tetanus, and influenza vaccines [14]. These aggressive policies had led to a significant 
increase in immunized dentists against a wide array of occupational infections during re-
cent years in some low- and low-middle-income economies [15,16]. Nevertheless, dental 
students’ knowledge and attitudes towards the relatively novel and nonmandatory vac-
cines, such as the human papillomavirus (HPV) vaccine, remained suboptimal in coun-
tries of various economic capacities, e.g., India, Saudi Arabia, and the United States of 
America (USA) [17–19]. 
Clinical-year dental students were found to have substantially higher levels of posi-
tive attitudes and knowledge towards HPV and hepatitis B vaccines, respectively, com-
pared to their pre-clinical peers [19,20]. Farsi et al. (2020) had found that female dental 
students showed a significantly higher level of HPV vaccine acceptance than their male 
peers [19]. Similarly, Rutkoski et al. (2020) found that female dental students were more 
knowledgeable about the HPV vaccine [18]. The conspiracy beliefs and misconception 
about the immunity system played a decisive role in decreasing the university students’ 
acceptance level of the COVID-19 vaccine [21]. However, there is a lack of worldwide 
evidence on COVID-19 VH levels and their association with the economy; the indirect 
evidence suggests that economic hardship is a clear determinant of VH among individuals 
in the same country [22]. In a recent Italian cross-sectional study, the recovered COVID-
19 patients showed substantial levels of VH towards the COVID-19 vaccine (59.2%) and 
influenza vaccine (54.6%) [23]. Older age and previous 2019 influenza shots were the main 
predictors of positive attitudes towards vaccination [23]. 
Social media platforms play a key role in communicating health-related information, 
including pro- and anti-vaccination messages, which can affect public opinion about vac-
cines, their effectiveness, and safety [24]. A recent cross-sectional study revealed that mis-
trust of government was strongly correlated with vaccine hesitancy among the Austrian 
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population; thus, suggesting that disengagement from public discourse endangers vac-
cination strategies [25]. Religious and cultural values can also undermine the willingness 
to receive the vaccines; therefore, there are emerging calls for urgent interventions to con-
front misconceptions about vaccines through religious institutions [26]. Therefore, WHO 
SAGE acknowledged social media, mistrust of government and pharmaceutical industry, 
and personal beliefs as contextual drivers of vaccine hesitancy [2]. In addition, general 
attitudes towards newly developed vaccines, knowledge about vaccine safety and effec-
tiveness, and availability of vaccines are depicted by the WHO SAGE as personal/social 
and vaccine-specific drivers of VH [2]. 
The primary objective of this study was to estimate the prevalence of COVID-19 VH 
among a global sample of dental students. The secondary objectives were to explore the 
potential drivers for VH of dental students and to evaluate their impact on students’ ac-
ceptance of the COVID-19 vaccine. 
2. Materials and Methods 
2.1. Study Design 
A cross-sectional survey-based study was carried out between the 6th and 28th Feb-
ruary 2021 by the national and local member organizations of the International Associa-
tion of Dental Students (IADS) [27]. The study utilized an online self-administered ques-
tionnaire (SAQ) of multiple-choice items developed through KoBoToolbox (Harvard Hu-
manitarian Initiative, Cambridge, MA, USA, 2021) [28]. 
After ethical clearance, invitation emails were sent to all the national and local dele-
gates of IADS to participate in this cross-sectional study aiming to evaluate the attitudes 
of dental students worldwide towards the COVID-19 vaccine. Online orientation sessions 
were held to demonstrate the study objectives and the role of national and local coordina-
tors in this study who were primarily concerned with survey dissemination and data col-
lection. The Standing Committee on Research and Education (SCORE) of IADS was in 
charge of supervising the whole project and facilitating communication among the na-
tional and local coordinators [29]. The study was conducted and reported according to the 
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) state-
ment for cross-sectional studies [30]. 
2.2. Participants 
The target population of this study was the undergraduate dental students in the 
participating countries. Given the global variability of dental education systems, students 
of the compulsory training year (dental interns) and the students who graduated within 
the last 12 months were included. The participation in this study was voluntary, and the 
participants were not financially compensated and received no other means of incentives 
to limit selection bias. All participants provided their digital informed consent prior to 
filling in the questionnaire, and they were offered to withdraw from the study at any mo-
ment before submitting their answers without justification. 
The national and local coordinators used various methods to circulate the uniform 
resource locator (URL) of the questionnaire, including social media platforms (Facebook, 
Twitter, and Instagram), instant messaging groups (WhatsApp and WeChat), and distri-
bution lists of their organizations and universities. 
The pragmatic sample size of participating countries was calculated using Epi-InfoTM 
version 7.2.4 (CDC, Atlanta, GA, USA, 2020) according to the total number of dental stu-
dents in each participating country and assuming 50% of outcome probability with a con-
fidence level of 95% and an error margin of 5% [31] (Supplementary File, Table S1). 
A total of 6680 students participated in this study, with 41 students having filled in 
the questionnaire improperly; therefore, they were excluded from the final analyses. 
  




The SAQ consisted of 20 multiple-choice items which required on average 7–9 min 
to be completed, and it was divided into four categories: (a) demographic data, including 
gender, age, academic level, and country; (b) COVID-19-related experience, including pre-
vious infection, providing care to a COVID-19 patient, having a COVID-19 patient within 
the social circle, and having a deceased COVID-19 patient within the social circle; (c) will-
ingness to take the COVID-19 vaccine determined by a 5-point Likert scale; and (d) the 
drivers of COVID-19 vaccine-related attitude (Supplementary File; Table S2). 
The items of the fourth category were adopted from the compendium validated by 
the WHO SAGE [2]. The impact of media/social media, influential leaders and gatekeep-
ers, trust in government, trust in pharmaceutical companies, and personal, religious, and 
cultural values were selected as the contextual drivers, while the beliefs of health and nat-
ural immunity, and perceived knowledge sufficiency were depicted as the individual 
drivers. Out of the vaccine-specific drivers’ group, the risk to benefit ratio of administer-
ing the COVID-19 vaccine, introducing a new vaccine, and the vaccine availability were 
selected. The items were selected by a panel of experts in medical education and public 
health, the selection criteria were the relevance of the items to the COVID-19 vaccines 
context [2]. 
The experts’ panel reviewed the appropriateness and clarity of the suggested ques-
tionnaire to determine its content validity. Consequently, 18 dental students were re-
cruited to fill in the questionnaire twice, with a minimum interval of 48 h to evaluate its 
reliability. The mean Cohen’s kappa coefficient of the test re-test was 81.83 ± 0.16 (0.55–1), 
indicating that the questionnaire retained a perfect level of reliability (Table 1). 
Table 1. The results of the test re-test reliability 1. 
Participant κ Coefficient Participant κ Coefficient 
No. 1 0.8 No. 10 0.6 
No. 2 0.8 No. 11 1.0 
No. 3 0.9 No. 12 0.7 
No. 4 1.0 No. 13 1.0 
No. 5 1.0 No. 14 0.8 
No. 6 0.6 No. 15 0.7 
No. 7 0.6 No. 16 1.0 
No. 8 1.0 No. 17 0.8 
No. 9 0.6 No. 18 0.8 
1 Cohen’s Kappa statistic (κ): 0.01–0.2 as none to slight, 0.21–0.4 as fair, 0.41–0.6 as moderate, 0.61–
0.80 as substantial, and 0.81–1.0 as perfect agreement [32]. 
2.4. Ethical Considerations 
The study protocol was reviewed and approved by the Ethics Committee of the Fac-
ulty of Medicine, Masaryk University (MUNI) on 20th January 2021 with reference No. 
4/2021. The questionnaire collected no identifying personal data from the participants. 
The study data were collected and managed by MUNI in full compliance with the Euro-
pean General Data Protection Regulation 2016/679 (GDPR) [33]. 
2.5. Statistical Analysis 
The Statistical Package for the Social Sciences (SPSS) version 27 (SPSS Inc. Chicago, 
IL, USA, 2020) was used to perform all the statistical tests [34]. Primarily, descriptive anal-
ysis was performed for the demographic variables, COVID-19-related experience, willing-
ness to take the COVID-19 vaccine, and the drivers of COVID-19 vaccine-related attitude 
represented by frequencies, percentages, cumulative percentages, means, and standard 
deviations. Consequently, the students were classified according to their academic level 
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as pre-clinical (1st year and 2nd year) and clinical (3rd year–fresh graduate). The partici-
pating countries were also stratified into four groups according to the latest ranking of the 
World Bank (the fiscal year 2021) as low-income economies, lower-middle-income econo-
mies, upper-middle-income economies, and high-income economies [35]. Inferential sta-
tistics were carried out to evaluate the association of the COVID-19 vaccine acceptance 
level and demographic variables using the Mann–Whitney U-test and the Kruskal–Wallis 
test. Similarly, the vaccine acceptance level and its associated drivers were evaluated us-
ing the Mann–Whitney U-test with a confidence level of 95% and significance value (p) ≤ 
0.05. 
3. Results 
3.1. Demographic Characteristics 
Out of the 6639 included students, 4682 (70.5%) were females, 1836 (27.7%) were 
males, 53 (0.8%) were non-binary, and 68 (1%) preferred not to disclose their gender. The 
mean age of participants was 22.06 ± 2.79 (17–40) years. While 2206 (33.2%) participants 
were pre-clinical students, 4433 (66.8%) were in clinical years. 
The participating students were from 22 countries: 57 (0.9%) from Albania, 183 (2.8%) 
from Canada, 169 (2.5%) from Croatia, 381 (5.7%) from Ecuador, 78 (1.2%) from Estonia, 
416 (6.3%) from Indonesia, 388 (5.8%) from Iran, 354 (5.3%) from Iraq, 492 (7.4%) from 
Italy, 129 (1.9%) from Latvia, 107 (1.6%) from Lebanon, 291 (4.4%) from Lithuania, 350 
(5.3%) from Malaysia, 153 (2.3%) from Nepal, 379 (5.7%) from Pakistan, 417 (6.3%) from 
Palestine, 389 (5.9%) from Portugal, 596 (9%) from Russia, 467 (7%) from Sudan, 283 (4.3%) 
from Tunisia, 386 (5.8%) from Turkey, and 174 (2.6%) from the USA. 
According to the latest ranking of the World Bank (the fiscal year 2021), 467 (7%) of 
the participants were from low-income economies, 1232 (18.6%) from lower-middle-in-
come economies, 3035 (45.7%) from upper-middle-income, and 1905 (28.7%) from high-
income economies [35]. According to the World Dental Federation (FDI) geographical cat-
egorization, 750 (11.3%) were from Africa, 738 (11.1%) from the Americas, 1298 (19.6%) 
from Asia-Pacific, 1266 (19.1%) from Eastern Mediterranean, and 2587 (39%) from Europe 
[36] (Table 2). 
Table 2. Demographic characteristics of the participating dental students worldwide, February 2021. 
Variable Outcome Frequency Percentage Cumulative Percentage 
Gender 
Female 4682 70.5% 70.5% 
Male 1836 27.7% 98.2% 
Non-binary 53 0.8% 99% 
Prefer not to say 68 1% 100% 
Age 17–22 years 4218 63.5% 63.5% 
23–40 years 2421 36.5% 100% 
Academic Level 
1st Year 979 14.7% 14.7% 
2nd Year 1227 18.5% 33.2% 
3rd Year 1422 21.4% 54.6% 
4th Year 1259 19% 73.6% 
5th Year 817 12.3% 85.9% 
6th Year 240 3.6% 89.5% 
Internship 322 4.9% 94.4% 
Fresh Graduate 373 5.6% 100% 
Country 
Albania 57 0.9% 0.9% 
Canada 183 2.8% 3.6% 
Croatia 169 2.5% 6.2% 
Ecuador 381 5.7% 11.9% 
Estonia 78 1.2% 13.1% 
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Indonesia 416 6.3% 19.3% 
Iran 388 5.8% 25.2% 
Iraq 354 5.3% 30.5% 
Italy 492 7.4% 37.9% 
Latvia 129 1.9% 39.9% 
Lebanon 107 1.6% 41.5% 
Lithuania 291 4.4% 45.9% 
Malaysia 350 5.3% 51.1% 
Nepal 153 2.3% 53.4% 
Pakistan 379 5.7% 59.2% 
Palestine 417 6.3% 65.4% 
Portugal 389 5.9% 71.3% 
Russia 596 9.0% 80.3% 
Sudan 467 7.0% 87.3% 
Tunisia 283 4.3% 91.6% 
Turkey 386 5.8% 97.4% 
USA 174 2.6% 100% 
Geographic  
Region 
Africa 750 11.3% 11.3% 
Americas 738 11.1% 22.4% 
Asia-Pacific 1298 19.6% 41.9% 
Eastern Mediterranean 1266 19.1% 61% 
Europe 2587 39% 100% 
Economic Level 
Low-income Economy 467 7% 7% 
Lower-middle-income Economy 1232 18.6% 25.6% 
Upper-middle-income Economy 3035 45.7% 71.3% 
High-income Economy 1905 28.7% 100% 
3.2. COVID-19-Related Experience 
A total of 1105 (16.6%) students reported that they had been previously infected by 
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The students from low- 
and lower-middle-income economies (LLMI) were significantly (χ2 = 13.81; p < 0.01) more 
infected by COVID-19 compared to the students from upper-middle- and high-income 
economies (UMHI), 19.5% vs. 15.6% respectively. While 538 (31.7%) students from LLMI 
provided care to COVID-19 patients, 1270 (25.7%) students from UMHI provided such 
care with a statistically significant difference (χ2 = 22.64; p < 0.01). 
The same pattern was found with having COVID-19 patients within students’ social 
circles, as 1515 (89.2%) students from LLMI versus 4286 (86.8%) students from UMHI 
knew personally COVID-19 patients (χ2 = 6.65; p = 0.01); with having deceased COVID-19 
patients within students’ social circles, as 945 (55.6%) students from LLMI versus 2086 
(42.2%) students from UMHI reported to having known someone who died from COVID-
19 infection (χ2 = 91.41; p < 0.01) (Table 3). 
Table 3. COVID-19-related experience of the dental students stratified by economic level, February 2021. 
Variable LLMI UMHI Total Sig. 1 
I had been infected by SARS-CoV-2 332 (19.5%) 773 (15.6%) 1105 (16.6%) <0.01 
I had been caring for someone with COVID-19 infection 538 (31.7%) 1270 (25.7%) 1808 (27.2%) <0.01 
I know someone who had COVID-19 infection 1515 (89.2%) 4286 (86.8%) 5801 (87.4%) 0.01 
I know someone who had died from COVID-19 infection 945 (55.6%) 2086 (42.2%) 3031 (45.7%) <0.01 
1 Chi-squared test was used with a significance level ≤0.05. 
The clinical students were significantly more affected by the COVID-19 pandemic 
than their preclinical peers, as 17.6% vs. 14.7% were previously infected (χ2 = 9.12; p = 
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0.003), 28.1% vs. 25.5% provided care to COVID-19 patients (χ2 = 5.15; p = 0.023), 88.9% vs. 
84.2% knew personally COVID-19 patients (χ2 = 29.78; p < 0.01), and 47.4% vs. 42.2% knew 
someone who died from COVID-19 infection (χ2 = 15.86; p < 0.01). 
Male students were significantly (χ2 = 22.67; p < 0.01) more infected by COVID-19 
compared to their female peers, 19.8% vs. 14.9% respectively. Moreover, 584 (31.8%) males 
versus 1170 (25%) females provided care to COVID-19 patients (χ2 = 31.18; p < 0.01). Con-
trarily, female students knew personally COVID-19 patients more than male students, 
87.8% vs. 86.8% respectively (χ2 = 1.26; p = 0.268). Similarly, more females knew deceased 
COVID-19 patients, 45.9% vs. 45.1% (χ2 = 0.32; p = 0.57). 
The highest countries with previously infected students were Albania (43.9%), Iran 
(34.3%), Tunisia (31.1%), Lebanon (29%), Ecuador (24.9%), Russia (23.7%), and the USA 
(20.1%). The highest countries with students providing care to COVID-19 patients were 
Iran (49.7%), Albania (49.1%), Tunisia (42%), Iraq (38.4%), Lebanon (36.4%), Palestine 
(35.3%), and Russia (33.4%). 
3.3. COVID-19 Vaccine-Related Attitudes 
Regarding their attitudes towards the COVID-19 vaccine, 491 (7.4%) students totally 
disagreed with taking the vaccine, 434 (6.5%) disagreed, 1494 (22.5%) were hesitant about 
taking the vaccine, 1495 (22.5%) agreed, and 2725 (41%) totally agreed (Table 4). 
Table 4. Dental students’ attitudes towards the COVID-19 vaccine stratified by economic level, February 2021. 
Variable Outcome LLMI UMHI Total Sig. 1 
I am willing to take the COVID-19  
vaccine once it becomes available to me. 
Totally Disagree = 1 150 (8.8%) 341 (6.9%) 491 (7.4%) 0.01 
Disagree = 2 126 (7.4%) 308 (6.2%) 434 (6.5%) 0.09 
Not Sure = 3 517 (30.4%) 977 (19.8%) 1494 (22.5%) <0.01 
Agree = 4 441 (26%) 1054 (21.3%) 1495 (22.5%) <0.01 
Totally Agree = 5 465 (27.4%) 2260 (45.7%) 2725 (41%) <0.01 
Total (1–5) 3.56 ± 1.21 3.93 ± 1.23 3.83 ± 1.24 <0.01 
1 Chi-squared and Mann–Whitney U-test were used with a significance level ≤0.05. 
The LLMI students were significantly (χ2 = 82.26; p < 0.01) more hesitant to take the 
vaccine than their UMHI peers, 30.4% vs. 19.8%, respectively. The highest percentage of 
hesitant students were from low-income economies (37.5%), followed by lower-middle-
income economies (27.8%), upper-middle-income economies (25.2%), and high-income 
economies (11.1%). Similarly, the highest percentage of resistant students were from low-
income economies (18.6%), and the lowest percentage was from high-income economies 
(7.3%). Contrarily, the lowest agreement level was in low-income economies (43.9%), fol-
lowed by lower-middle-income economies (56.9%), upper-middle-income economies 
(58%), and high-income economies (81.6%). 
3.4. Drivers of COVID-19 Vaccine-Related Attitude 
The LLMI students were more significantly (U = 3,436,031; p < 0.01) influenced by the 
reports they heard and read in media and social media compared to their UMHI peers, 
42% vs. 30.4%, respectively. They were also more significantly (U = 3,832,308; p < 0.01) 
influenced by celebrities, religious and political leaders, 21.3% vs. 14.5%. 
In terms of confidence in government and pharmaceutical companies, the UMHI stu-
dents (37.9% and 51% respectively) were more significantly (U = 3,608,480, 3,526,701; p < 
0.01, <0.01 respectively) confident than their LLMI peers (27.1% and 37% respectively). 
While the UMHI students were more aware of people with religious and cultural values 
who retained them from taking vaccines, 25% vs. 17% respectively, the LLMI students 
were more agreeable with this antivaccination stand, 18% vs. 10.9% respectively. 
Regarding the individual drivers, 38.1% of LLMI students thought that there was 
better ways to prevent COVID-19 than using vaccines versus 22.4% of UMHI students (U 
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= 3,514,137; p < 0.01). Additionally, the UMHI students were significantly (U = 3,707,403; 
p < 0.01) more confident that they had enough information about COVID-19 vaccines and 
their safety compared to their LLMI peers, 33.1% vs. 27%, respectively. 
All the vaccine-specific drivers were significantly in favour of UMHI, as 54.4% of 
UMHI students had higher levels of beliefs that the benefits of COVID-19 vaccines out-
weigh their reported side effects compared to only 40.2% of LLMI students. Moreover, 
45.2% of UMHI students were more inclined to take a newly introduced vaccine versus 
37.6% of LLMI students. Similarly, 43.2% of UMHI students felt confident that their health 
centres would have the COVID-19 vaccine whenever needed compared to only 33.6% of 
LLMI students (Table 5). 
Table 5. Dental students’ vaccine-related attitude drivers stratified by economic level, February 2021. 
Variable Outcome LLMI UMHI Total Sig. 1 
Contextual Drivers 
Do reports you hear/read in the media/on social 
media make you re-consider the choice to take the 
COVID-19 vaccine? 
Yes = 2 713 (42%) 1504 (30.4%) 2217 (33.4%) 
 Not Sure = 1 464 (27.3%) 1055 (21.4%) 1519 (22.9%) 
No = 0 522 (30.7%) 2381 (48.2%) 2903 (43.7%) 
Total (0–2) 1.11 ± 0.85 0.82 ± 0.87 0.9 ± 0.87 <0.01 
Do celebrities, religious or political leaders  
influence your decision about being vaccinated? 
Yes = 2 362 (21.3%) 716 (14.5%) 1078 (16.2%) 
 Not Sure = 1 227 (13.4%) 600 (21.1%) 827 (12.5%) 
No = 0 1110 (65.3%) 3624 (73.4%) 4734 (71.3%) 
Total (0–2) 0.56 ± 0.82 0.41 ± 0.73 0.45 ± 0.76 <0.01 
Do you trust that your government is making  
decisions in your best interest with respect to what 
vaccines are provided (e.g., your government  
purchases the highest quality vaccines available)? 
Yes = 2 460 (27.1%) 1871 (37.9%) 2331 (35.1%) 
 Not Sure = 1 550 (32.4%) 1580 (32%) 2130 (32.1%) 
No = 0 689 (40.6%) 1489 (30.1%) 2178 (32.8%) 
Total (0–2) 0.87 ± 0.81 1.08 ± 0.82 1.02 ± 0.82 <0.01 
Do you trust pharmaceutical companies to  
provide credible data on COVID-19 vaccine safety 
and the effectiveness of the vaccines? 
Yes = 2 629 (37%) 2521 (51%) 3150 (47.4%) 
 Not Sure = 1 579 (34.1%) 1462 (29.6%) 2041 (30.7%) 
No = 0 491 (28.9%) 957 (19.4%) 1448 (21.8%) 
Total (0–2) 1.08 ± 0.81 1.32 ± 0.78 1.26 ± 0.79 <0.01 
Do you know anyone who will not take the vac-
cine because of religious or cultural values? 
Yes = 2 289 (17%) 1234 (25%) 1523 (22.9%) 
 Not Sure = 1 181 (10.7%) 649 (13.1%) 830 (12.5%) 
No = 0 1229 (72.3%) 3057 (61.9%) 4286 (64.6%) 
Total (0–2) 0.45 ± 0.77 0.63 ± 0.86 0.58 ± 0.84 <0.01 
If “Yes”, do you agree with these people? 
Yes = 2 52 (18%) 135 (10.9%) 187 (12.3%) 
 Not Sure = 1 30 (10.4%) 162 (13.1%) 192 (12.6%) 
No = 0 207 (71.6%) 937 (75.9%) 1144 (75.1%) 
Total (0–2) 0.46 ± 0.78 0.35 ± 0.67 0.37 ± 0.69 <0.01 
Individual/Group Drivers 
Do you think that there are better ways to prevent 
COVID-19 than using vaccines (e.g., developing 
immunity by becoming sick and recovering)? 
Yes = 2 647 (38.1%) 1109 (22.4%) 1756 (26.4%) 
 Not Sure = 1 432 (25.4%) 1523 (30.8%) 1955 (29.4%) 
No = 0 620 (36.5%) 2308 (46.7%) 2928 (44.1%) 
Total (0–2) 1.02 ± 0.86 0.76 ± 0.8 0.82 ± 0.82 <0.01 
Do you feel you have enough information about 
COVID-19 vaccines and their safety? 
Yes = 2 458 (27%) 1633 (33.1%) 2091 (31.5%) 
 Not Sure = 1 399 (23.5%) 1439 (29.1%) 1838 (27.7%) 
No = 0 842 (49.6%) 1868 (37.8%) 2710 (40.8%) 
Total (0–2) 0.77 ± 0.85 0.95 ± 0.84 0.91 ± 0.845 <0.01 
Vaccine-specific Drivers 
Yes = 2 683 (40.2%) 2686 (54.4%) 3369 (50.7%) 
 
Not Sure = 1 661 (38.9%) 1421 (28.8%) 2082 (31.4%) 
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Do you think that the benefits of COVID-19  
vaccines outweigh their reported side effects/ 
adverse reactions? 
No = 0 355 (20.9%) 833 (16.9%) 1188 (17.9%) 
Total (0–2) 1.19 ± 0.76 1.38 ± 0.76 1.33 ± 0.76 <0.01 
In general, when a new vaccine is introduced,  
are you inclined to consent to your vaccination? 
Yes = 2 638 (37.6%) 2233 (45.2%) 2871 (43.2%) 
 Not Sure = 1 556 (32.7%) 1606 (32.5%) 2162 (32.6%) 
No = 0 505 (29.7%) 1101 (22.3%) 1606 (24.2%) 
Total (0–2) 1.08 ± 0.82 1.23 ± 0.79 1.19 ± 0.8 <0.01 
Do you feel confident that the health centre or 
doctor’s office will have the COVID-19 vaccines 
you need, when you need them? 
Yes = 2 571 (33.6%) 2132 (43.2%) 2703 (40.7%) 
 Not Sure = 1 617 (36.3%) 1541 (31.2%) 2158 (32.5%) 
No = 0 511 (30.1%) 1267 (25.6%) 1778 (26.8%) 
Total (0–2) 1.04 ± 0.8 1.18 ± 0.81 1.14 ± 0.81 <0.01 
1 Mann–Whitney U-test was used with a significance level ≤0.05. 
Males had significantly higher levels of belief of natural immunity superiority over 
vaccines and perceived knowledge sufficiency (U = 4,139,866, 3,758,515; p = 0.01, <0.01 
respectively). Females had lower levels of confidence in government (34.6% vs. 37.4%), 
confidence in pharmaceutical companies (47.5% vs. 47.9%), belief that COVID-19 benefits 
outweigh its reported side effects (50.1% vs. 53.5%), and inclination to take newly intro-
duced vaccines (42.1% vs. 46.8%). Across academic levels, the fresh graduates were the 
least informed about COVID-19 vaccine safety, and they were the most supportive of the 
belief of natural immunity superiority over vaccines. 
3.5. Demographic Determinants of COVID-19 Vaccine-Related Attitude 
The acceptance level of the COVID-19 vaccine ranged between one denoting “totally 
disagree”, and five denoting “totally agree”. The mean acceptance level of males was sig-
nificantly (U = 4,165,947; p = 0.04) higher than females; it was also higher than non-binary 
students (3.47 ± 1.42) and the students who did not disclose their gender (3.44 ± 1.43). 
The fifth-year students were the most accepting (3.93 ± 1.25); however, the interns 
were the least accepting (3.59 ± 1.26). Overall, the clinical students were significantly (U = 
4,655,705; p = 0.01) more accepting compared to the pre-clinical students (Table 6). 
Table 6. Dental students’ demographic determinants of COVID-19 acceptance, February 2021. 
Variable Outcome Acceptance Level Sig. 1 
Gender 
Female 3.83 ± 1.23 
0.01 
Male 3.87 ± 1.26 
Non-binary 3.47 ± 1.42 
Prefer not to say 3.44 ± 1.43 
Academic Level 
1st Year 3.73 ± 1.28 
0.11 
2nd Year 3.81 ± 1.19 
3rd Year 3.91 ± 1.19 
4th Year 3.90 ± 1.25 
5th Year 3.93 ± 1.25 
6th Year 3.80 ± 1.31 
Internship 3.59 ± 1.26 
Fresh Graduate 3.66 ± 1.26 
Clinical Training 
Preclinical (1st year and 2nd 
year) 
3.77 ± 1.32 
0.01 
Clinical (3rd year–Graduate) 3.86 ± 1.24 
Country 
Albania 3.14 ± 1.27 
<0.01 Canada 4.41 ± 1 
Croatia 3.73 ± 1.26 
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Ecuador 3.86 ± 1.19 
Estonia 3.62 ± 1.22 
Indonesia 4.37 ± 0.89 
Iran 3.38 ± 1.38 
Iraq 3.27 ± 1.17 
Italy 4.7 ± 0.8 
Latvia 3.8 ± 1.37 
Lebanon 3.86 ± 1.18 
Lithuania 4.18 ± 1.12 
Malaysia 4.33 ± 0.91 
Nepal 3.91 ± 1.04 
Pakistan 3.97 ± 1.01 
Palestine 3.72 ± 1.27 
Portugal 4.57 ± 0.85 
Russia 2.85 ±1.12 
Sudan 3.37 ± 1.17 
Tunisia 2.88 ± 1.2 
Turkey 3.99 ± 1.11 
USA 4.53 ± 1.04 
Geographic Region 
Africa 3.18 ± 1.2 
<0.01 
Americas 4.15 ± 1.15  
Asia-Pacific 4.19 ± 1 
Eastern Mediterranean 3.5 ± 1.29 
Europe 3.91 ± 1.26 
Economic Level 
Low-income Economy 3.37 ± 1.17 
<0.01 
Lower-middle-income Economy 3.63 ± 1.23 
Upper-middle-income Economy 3.66 ± 1.25 
High-income Economy 4.36 ± 1.07 
1 Mann–Whitney U and Kruskal–Wallis tests were used with a significance level ≤0.05. 
In the high-income group, Italy was the most accepting country (4.7 ± 0.8), followed 
by Portugal (4.57 ± 0.85) and the USA (4.53 ± 1.04), while Estonia was the least accepting 
one (3.62 ± 1.22). In the upper-middle-income group, Indonesia was the most accepting 
country (4.37 ± 0.89), followed by Malaysia (4.33 ± 0.91) and Turkey (3.99 ± 1.11), while 
Russia was the least accepting one (2.85 ± 1.12). Pakistan was the most accepting lower-
middle-income country (3.97 ± 1.01), and Tunisia was the least accepting lower-middle-
income country (2.88 ± 1.2) (Figure 1). 
Africa was the least accepting region (3.18 ± 1.2), followed by Eastern Mediterranean 
(3.5 ± 1.29), and the Americas was the most accepting region (4.15 ± 1.15). Across the eco-
nomic ranking, the vaccine acceptance level was gradually distributed with the least ac-
cepting being the low-income group (3.37 ± 1.17), and the most accepting being the high-
income group (4.36 ± 1.07). The difference between the lower-middle-income group (3.63 
± 1.23) and upper-middle-income group (3.66 ± 1.25) was slight and statistically insignifi-
cant (U = 1,833,237; p = 0.302) (Figure 2). 




Figure 1. Dental students’ COVID-19 vaccine acceptance level by state, February 2021. 
 
(a) 





Figure 2. Dental students’ COVID-19 vaccine acceptance by (a) economic level and (b) geographic region, February 2021. 
Regarding their COVID-19-related experience, the students who had been previously 
infected were significantly (U = 2,677,855; p < 0.01) less accepting (3.57 ± 1.36), also the 
students who provided care to COVID-19 patients were significantly (U = 4,004,539; p < 
0.01) less accepting (3.68 ± 1.31). However, having a COVID-19 patient within students’ 
social circles was significantly (U = 2,219,499; p < 0.01) associated with a higher acceptance 
level of COVID-19 vaccine (3.86 ± 1.24), and having a deceased COVID-19 patient within 
students’ social circles was significantly (U = 5,175,777; p < 0.01) lowering the COVID-19 
vaccine acceptance (3.77 ± 1.26) (Table 7). 
Table 7. Dental students’ COVID-19 vaccine acceptance and COVID-19-related experience, February 2021. 
Variable No Yes Sig. 1 
I had been infected by SARS-CoV-2 3.88 ± 1.21 3.57 ± 1.36 <0.01 
I had been caring for someone with COVID-19 infection 3.89 ± 1.21 3.68 ± 1.31 <0.01 
I know someone who had COVID-19 infection 3.68 ± 1.25 3.86 ±1.24 <0.01 
I know someone who had died from COVID-19 infection 3.89 ± 1.22 3.77 ± 1.26 <0.01 
1 Mann–Whitney U-test was used with a significance level ≤0.05. 
3.6. Drivers of Dental Students’ COVID-19 Vaccine Acceptance 
3.6.1. Contextual Drivers 
Globally, the dependence on media and social media to inform vaccine-related deci-
sion was significantly (U = 2,678,371; p < 0.01) associated with a decreased level of vaccine 
acceptance (3.71 ± 1.21). Similarly, the reliance on public figures and opinion leaders was 
insignificantly (U = 2,495,719; p = 0.24) associated with a lower level of vaccine acceptance 
(3.82 ± 1.27). 
The confidence in government was significantly (U = 1,467,912; p < 0.01) associated 
with a higher level of vaccine acceptance (4.29 ± 1.10), also the confidence in pharmaceu-
tical companies improved vaccine acceptance (4.31 ± 1.06) significantly (U = 1,041,773; p < 
0.01). The students who agreed with the antivaccination stand based on cultural and reli-
gious values had significantly (U = 43,532; p < 0.01) much lower levels of vaccine ac-
ceptance (2.75 ± 1.44). 
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3.6.2. Individual Drivers 
The students who thought COVID-19 should be better prevented by natural immun-
ity than by vaccines had a significantly (U = 1,698,349; p < 0.01) lower level of vaccine 
acceptance (3.35 ± 1.38). Additionally, the students with insufficient knowledge about 
COVID-19 vaccine safety had a significantly (U = 1,766,800; p < 0.01) lower level of vaccine 
acceptance (3.48 ± 1.19). 
3.6.3. Vaccine-Specific Drivers 
The COVID-19 vaccine acceptance level was significantly decreased in the students 
who did not think that the vaccine’s benefits outweigh its reported side effects, the stu-
dents who were not inclined to take newly introduced vaccines, and the students who 
were not confident in finding the vaccine in their local health centre when needed (U = 
1,010,578, 974,557, 1,608,552; p < 0.01, <0.01, <0.01) respectively (Table 8). 
Table 8. Drivers of dental students’ COVID-19 vaccine acceptance worldwide, February 2021. 
Category Driver No Yes Sig. 1 
Contextual 
Media 3.99 ± 1.31 3.71 ± 1.21 <0.01 
Public Figures 3.87 ± 1.25 3.82 ± 1.27 0.24 
Government 3.37 ± 1.30 4.29 ± 1.10 <0.01 
Pharmaceuticals 3.06 ± 1.30 4.31 ± 1.06 <0.01 
Values 4.30 ± 1.05 2.75 ± 1.44 <0.01 
Individual/Group 
Natural Immunity 4.16 ± 1.11 3.35 ± 1.38 <0.01 
Sufficient Knowledge 3.48 ± 1.19 4.21 ± 1.23 <0.01 
Vaccine-specific 
Risk/Benefit Ratio 3.14 ± 1.37 4.31 ± 1.06 <0.01 
New Vaccine 3.06 ± 1.28 4.37 ± 1.03 <0.01 
Availability 3.44 ± 1.3 4.17 ± 1.15 <0.01 
1 Mann–Whitney U-test was used with a significance level ≤0.05. 
4. Discussion 
Globally, 22.5% of dental students within our sample were hesitant about taking 
COVID-19 vaccines. Verger et al. (2021) found that 28.39% of healthcare workers in France 
and French-speaking parts of Belgium and Canada were hesitant about COVID-19 vac-
cines [37]. The findings of Verger et al. (2021) were a bit close to what had been found in 
Malta (22%), Portugal (21%), Germany (20%), the Netherlands (19%), and Italy (19%) 
[38,39]. On the other hand, the studies that sampled general university students showed 
a wide range of hesitancy about COVID-19 vaccines, ranging between Egypt (46%), Jor-
dan (25.5%), Malta (25.3%), the USA (19.3%), and India (10.6%) [21,40–43]. 
As representatives of the healthcare student population, dental students have a cru-
cial role in disseminating robust information about COVID-19 vaccines’ effectiveness and 
safety [6]. This social role is backed by the prevailing evidence on healthcare professionals’ 
impact on shaping public opinion regarding health issues, including vaccination [8,9]. 
Dental students are also threatened by an array of occupational infections due to their 
clinical training; therefore, compulsory vaccination strategies for pre-clinical students had 
been increasingly implemented in recent years [15]. Although positive attitudes are pre-
dicted from dental students towards vaccines as they are used to receiving them, they 
demonstrated suboptimal levels of knowledge and attitudes towards new vaccines 
[18,19]. 
In the current study, the economic level was a significant determinant of dental stu-
dents’ VH, as 37.5% of low-income, 27.8% of low-middle-income, 25.2% of upper-middle-
income, and 11.1% of high-income economies students were hesitant about COVID-19 
vaccines. This socioeconomic gradient of VH has been recently found among population 
groups in Italy, where perceived levels of economic hardship were significantly associated 
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with VH [22]. However, there is a lack of evidence on the relationship between the eco-
nomic level and vaccines acceptance from a global perspective; a recent systematic review 
showed that the highest acceptance level among healthcare workers was in a high-income 
country, Israel (78.1%), while the lowest level was in a low-income country, the Demo-
cratic Republic of the Congo (27.7%) [44]. Regardless of their methodological heterogene-
ity, cross-sectional studies showed that acceptance levels of medical students in UMHI 
countries such as Italy (86.1%) and Poland (92%) were much higher than LLMI countries 
such as Egypt (35%) [40,45,46]. 
The socioeconomic gradient of VH can be better understood in light of the contextual, 
individual, and vaccine-specific drivers endorsed by the WHO SAGE. The students of 
UMHI countries had significantly lower levels of dependence on media/social media 
(30.4% vs. 42%; p < 0.01), were less influenced by public figures (14.5% vs. 21.3%; p < 0.01), 
had less mistrust of government (30.1% vs. 40.6%; p < 0.01), less mistrust of the pharma-
ceutical industry (19.4% vs. 28.9%; p < 0.01), less readiness to reject vaccines based on per-
sonal/cultural/religious values (10.9% vs. 18%; p = 0.003), and less misconception about 
natural immunity (22.4% vs. 38.1%; p < 0.01) than their colleagues of LLMI countries. Con-
trarily, the students of UMHI countries had significantly higher levels of sufficient 
knowledge (33.1% vs. 27%; p < 0.01), knowledge of vaccine risk/benefit ratio (54.4% vs. 
40.2%; p < 0.01), willingness to take new vaccines (45.2% vs. 37.6%; p < 0.01), and confi-
dence about local availability of vaccines (43.2% vs. 33.6%; p < 0.01). 
Almost 70% of our sample was composed of female students, and this represents the 
actual female/male ratio of dental students globally. According to the latest report of the 
Council of European Dentists (CED), the dental profession is majorly practised by females 
in Europe [47]. The Health Policy Institute (HPI) of the American Dental Association 
(ADA) revealed that female dental practitioners had increased from 16% in 2001 to 34.5% 
in 2020, and this pattern is projected to continue given the steady increase in female dental 
students from 11.7% in 1979 to 51.6% in 2019 [48,49]. The global phenomenon of “femini-
zation of dentistry” is profoundly evident in low-income settings, including Central Asia, 
Africa, and South America [50–52]. 
Female dental students had a statistically significant higher level of COVID-19 VH 
(χ2 = 9.18; p = 0.02) than their male colleagues. This finding is in agreement with the recent 
systematic review of Sallam (2021) on COVID-19 vaccines, which revealed that males were 
more likely to accept vaccines [44]. In both LLMI and UMHI countries, female students 
had higher levels of VH (32% and 20.3%, respectively) than their male colleagues (25.6% 
and 18.3%, respectively). The emerging evidence on COVID-19 VH among general popu-
lation groups shows that females are less accepting for COVID-19 vaccines in UMHI coun-
tries such as the US, United Kingdom (UK), Portugal, Jordan, Kuwait, and Saudi Arabia 
and LLMI countries such as Nigeria, Bangladesh, and Ethiopia [21,53–58]. 
Pre-clinical dental students had a statistically significant higher level of COVID-19 
VH (χ2 = 7.39; p = 0.007) than their clinical colleagues. Lucia et al. (2020) found that clinical 
medical students (62%) were significantly more inclined to participate in vaccine trials 
than their pre-clinical colleagues (44%) in Michigan, USA [59]. This pattern was also found 
among medical students in India and Poland and dental students in the USA [43,46,60]. 
Apart from COVID-19 vaccines, the clinical medical students had higher acceptance levels 
of the influenza vaccine in Brazil, Germany and Saudi Arabia, and the human papilloma-
virus vaccine in India than their pre-clinical colleagues [61–64]. One reason to explain this 
is what Wicker et al. found in their 2013 study, where clinical students had higher levels 
of perceived occupational risk than pre-clinical students due to their proximity to blood- 
and air-borne infections; thus, explaining their increased likelihood to accept vaccination 
[64]. 
Previous infection with SARS-CoV-2 might be a barrier for vaccination, as the stu-
dents in our study who recovered from COVID-19 were considerably more resistant 
(20.4% vs. 12.6%) and slightly more hesitant (24.1% vs. 22.2%) to be vaccinated than their 
colleagues who were not infected. This finding confirms the results of a recent Italian 
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cross-sectional study, where the recovered COVID-19 patients showed substantial levels 
of VH towards the COVID-19 vaccine (59.2%) and influenza vaccine (54.6%) [23]. Simi-
larly, providing care to COVID-19 patients was also a barrier for vaccination, as the stu-
dents who looked after COVID-19 patients were considerably more resistant (18.2% vs. 
12.3%) and slightly more hesitant (23% vs. 22.3%) about vaccination. This can be explained 
by the fact that more than one-third of the students in our sample who provided care to 
COVID-19 patients had a high level of misconception about immunization. 
Using media and social media as the primary source of vaccine-related information 
was found to be another barrier to be willing to be vaccinated for dental students, as VH 
levels were significantly higher among the students who used media and social media in 
both UMHI countries and LLMI countries as their primary source of information. Li Ho 
et al. (2020) found that 27.5% of the most popular videos about COVID-19 on YouTube 
contained misleading information; thus, necessitating urgent interventions by health or-
ganizations to work proactively with content creators to disseminate high-quality videos 
[65]. The vaccine opposing content on Twitter was steadily increasing during the first half 
of 2020; thus, requiring thematic analysis of such content [66]. The discourse analysis of 
Griffith et al. (2021) for COVID-19 VH tweets found that concerns over safety, mistrust of 
governments and drug manufacturers, and insufficient knowledge about vaccines were 
the critical drivers of VH [67]. 
Trust in governments and their capacity to provide the best available vaccine was a 
significant suppressor of VH among dental students, as VH was reported by only 11.3% 
of the students who trusted their governments compared to 29.7% of the students who 
did not trust their governments. One of the lessons learned from the swine flu (H1N1) 
pandemic of 2009 was that vaccine acceptance levels during contagious outbreaks are 
prominently influenced by public confidence in the governments’ technical and organiza-
tional skills [68]. Similarly, trust in the pharmaceutical industry had a promoter role in 
COVID-19 vaccine acceptance, as VH was reported by only 11% of the students who 
trusted the pharmaceutical industry compared to 33% of the students who did not trust 
it. In the recent meta-analysis of Díaz Crescitelli et al. (2020), the lack of trust in the phar-
maceutical industry was found to be triggered by suspicions about their financial interests 
and their relationships with governments [69]. 
The perceived level of knowledge sufficiency about vaccines and their effectiveness 
was a significant determinant of COVID-19 vaccine acceptance among dental students 
globally. Male students had higher levels of sufficient knowledge than their female col-
leagues (39.8% vs. 28.3%; p < 0.01), and UMHI students were slightly more knowledgeable 
than LLMI students (33.1% vs. 27%; p < 0.01). VH was reported by 10.8% of the students 
with sufficient knowledge, while it was reported by 32.8% of the students with insufficient 
knowledge. For a better understanding of the role of perceived knowledge in vaccine ac-
ceptance, the perceived knowledge level was found to be associated with increased aware-
ness about the risk/benefit ratio of COVID-19 vaccination (U = 1,719,706.5; p < 0.01), a 
higher level of readiness to take new vaccines (U = 1,773,557; p < 0.01), and a lower level 
of misconception about immunization (U = 2,808,567; p = 0.576). Therefore, the results of 
this study call for urgent and further implementation of the epidemiology of infectious 
diseases education and vaccination trends within undergraduate dental curricula for bet-
ter preparation of dental students for future outbreaks [70–73]. 
Availability of vaccines was a significant promoter for COVID-19 vaccines ac-
ceptance among dental students globally, as the students who believed that COVID-19 
vaccines would be available for them were less hesitant (28.1% vs. 14.4%; p < 0.01). In the 
USA, COVID-19 vaccine acceptance levels increased gradually over the last months, 
which indicates that increasing trends of vaccine acceptance may correlate positively with 
the shift from hypothetical vaccines to the availability of real-world vaccines with sub-
stantial effectiveness and safety [74]. In the UMHI group, Italy was the most accepting 
country (4.7 ± 0.8), while Russia was the least accepting country (2.85 ± 1.12). On 1st March 
2021, 5.08% of the Italian population and only 2.48% of the Russian population received 
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at least one dose of COVID-19 vaccines [75]. In the LLMI group, Pakistan was the most 
accepting country (3.97 ± 1.01), while Tunisia was the least accepting country (2.88 ± 1.2). 
On 16th March 2021, 0.6% of the Pakistani population and 0% of the Tunisian population 
were vaccinated [75]. 
4.1. Study Strengths 
To the best of the authors’ knowledge, this is the first study to assess the prevalence 
of COVID-19 VH among dental students globally. The study also provides coherent evi-
dence on the impact of gender, clinical training, and economic level on the attitudes of 
dental students towards COVID-19 vaccination. The drivers of VH endorsed by the WHO 
SAGE were explored for the first time in the population of healthcare students, and they 
yielded revealing and conclusive results. 
4.2. Study Limitations 
The first limitation of this study is its sample which is not equally distributed across 
gender, but this can be simply justified as the sample aimed to be as representative as 
possible. The second limitation is the imbalanced representation of economic levels, and 
this occurred mainly due to the disproportionate geographic representation of the IADS. 
Lastly, the study is naturally limited as a cross-sectional study by its snapshot scope; how-
ever, VH levels had been dynamically changing over time, requiring ideally prospective 
cohort studies to monitor these trends. 
4.3. Study Implications 
Future research on VH among healthcare students should explore the role of univer-
sity curricula on students’ knowledge about vaccine effectiveness and safety. A concep-
tual model for the drivers of attitude towards vaccination among healthcare students, in-
cluding dental students, should be designed and validated using large datasets, such as 
our dataset that incorporate various variables of interest. Moreover, future research will 
benefit from prospective cohort studies as they can record the dynamics of attitudes to-
wards vaccines influenced by the emerging achievements and disruptions. The under-
graduate dental curricula have to functionally integrate components on infectious dis-
eases epidemiology, especially air-borne infections and vaccination trends, as part of their 
dental public health and infection control modules. Dental education needs to empower 
students with sufficient knowledge for making them ambassadors of high-quality health 
information and to spread the culture of trusting science. 
5. Conclusions 
The overall acceptance level (63.5%) of dental students for COVID-19 vaccines world-
wide was suboptimal. The worrisome level of VH (22.5%) was impacted by the economic 
context where the dental students live and study, as the students from high-income setting 
were more confident of receiving COVID-19 vaccines. The male gender and clinical train-
ing were also associated with an increased level of vaccines acceptance. The media and 
social media, public figures, insufficient knowledge about vaccines and their safety, and 
mistrust of governments and the pharmaceutical industry were barriers for vaccination. 
The findings of this global study call for further implementation of infectious diseases 
epidemiology education and vaccination trends within undergraduate dental curricula. 
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